Back to Results
First PageMeta Content
Alcohols / Euphoriants / Ketones / Phenols / Methadone / Buprenorphine / Opioid dependence / Substance dependence / Opioid / Chemistry / Organic chemistry / Morphinans


External Appraisal and Feedback Summary Guide Tasmanian Opioid Pharmacotherapy Policy and Clinical Practice Standards
Add to Reading List

Document Date: 2014-05-12 19:05:57

Open Document

File Size: 466,16 KB

Share Result on Facebook

Company

Alcohol / Builds / /

/

Event

Product Issues / Product Recall / /

Facility

Pharmacy Instructions / /

IndustryTerm

treatment services / pharmacotherapy services / combination product / pharmaceutical opioids / Online feedback / law enforcement / /

MedicalCondition

HIV / comorbid mental health disorders / Hepatitis B / thus improving withdrawal symptoms / Substance dependence / /

MedicalTreatment

pharmacotherapy / /

MusicAlbum

Alcohol / Performance / /

Organization

Western Australia Comparing Treatment Options Government / Drug and Alcohol Office / Department of Health / /

Person

Anita Reimann / /

/

Position

Governor / Manager Clinical Practice Development and Performance / physician / /

Product

naloxone / Suboxone / days / Subutex / /

ProvinceOrState

Western Australia / Tasmania / /

Region

Western Australia / /

Technology

Pharmacokinetics / /

URL

www.dhhs.tas.gov.au/mentalhealth/alcohol_and / www.dhhs.tas.gov.au/mentalhealth/alcohol_and_dru / /

SocialTag